StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-2.01%)

Close on Nov 17, 2026Market cap $457.03KP/E –Yield –

Arcadia Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Arcadia Biosciences's price to sales ratio was 0.1× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.1× to 4.6×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×−0.4
2025Dec 31, 20250.5×−1.2
2024Dec 31, 20241.8×+1.0
2023Dec 29, 20230.8×+0.1
2022Dec 30, 20220.6×−1.3
2021Dec 31, 20212.0×−18.8
2020Dec 31, 202020.8×−18.8
2019Dec 31, 201939.6×+33.4
2018Dec 31, 20186.2×+2.4
2017Dec 29, 20173.7×−6.5
2016Dec 30, 201610.2×−9.2
2015Dec 31, 201519.5×–

More Arcadia Biosciences figures

See a number that looks wrong?